Tarsus Pharmaceuticals Inc (TARS) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $75.87
• Market Cap: $3.08B
• EPS: $-1.99
• 52-Week High: $85.25
• 52-Week Low: $38.51

Market Sentiment

Tarsus Pharmaceuticals Inc currently has a Bullish sentiment score of 0.34.

About Tarsus Pharmaceuticals Inc

Tarsus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company based in Irvine, California, dedicated to advancing innovative therapeutic candidates specifically targeting ophthalmic diseases. With a pipeline centered around groundbreaking treatments for conditions such as dry eye disease and other vision-related disorders, Tarsus aims to fill significant unmet medical needs in the ophthalmic market. The company's commitment to robust clinical development supports its mission to e...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Tarsus Pharmaceuticals Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does TARS pay dividends?

Tarsus Pharmaceuticals Inc (TARS) does not currently pay a regular dividend.

What is TARS's market cap?

Tarsus Pharmaceuticals Inc (TARS) has a market capitalization of $3.08B with a current stock price of $75.87.